State of New Jersey Common Pension Fund D Takes $2.50 Million Position in Sotera Health Company $SHC

Key Points

• State of New Jersey Common Pension Fund D bought 141,619 shares of Sotera Health (NASDAQ:SHC) in Q4, a position worth about $2.5 million, and institutional investors now own roughly 91.03% of the company.
• Q1 results beat expectations: revenue rose ~10% to $280.1M and adjusted EPS was $0.18 (vs. $0.17 consensus), and the company reaffirmed FY‑2026 guidance while lifting adjusted EBITDA/margin commentary.
• Insider sale and leadership change: Director GTCR sold 10,000,000 shares for $152.7M (a ~44% reduction in that position), and Sotera announced a planned CEO transition to Alton Shader effective May 26, which could introduce near‑term execution risk.

State of New Jersey Common Pension Fund D acquired a new position in Sotera Health Company (NASDAQ:SHC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 141,619 shares of the company's stock, valued at approximately $2,498,000.

Several other large investors also recently added to or reduced their stakes in SHC. Empowered Funds LLC increased its holdings in Sotera Health by 11.1% in the 1st quarter. Empowered Funds LLC now owns 28,512 shares of the company's stock worth $332,000 after acquiring an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Sotera Health by 14.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company's stock worth $3,999,000 after acquiring an additional 43,471 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Sotera Health by 125.5% in the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company's stock worth $293,000 after acquiring an additional 14,018 shares during the last quarter. Creative Planning increased its holdings in Sotera Health by 15.3% in the 2nd quarter. Creative Planning now owns 20,186 shares of the company's stock worth $224,000 after acquiring an additional 2,673 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in Sotera Health by 4.2% in the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company's stock worth $3,549,000 after acquiring an additional 12,758 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on SHC shares. Zacks Research lowered Sotera Health from a "strong-buy" rating to a "hold" rating in a report on Friday, January 30th. Piper Sandler reissued an "overweight" rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday. Citigroup lifted their price objective on Sotera Health from $21.00 to $23.00 and gave the stock a "buy" rating in a report on Tuesday, February 24th. Wells Fargo & Company lowered Sotera Health to an "overweight" rating in a report on Thursday, January 8th. Finally, Barclays reduced their target price on Sotera Health from $20.00 to $18.00 and set an "overweight" rating for the company in a report on Tuesday, April 14th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $20.33.

Sotera Health Stock Up 3.1%

SHC stock opened at $15.80 on Thursday. The company has a quick ratio of 2.24, a current ratio of 2.82 and a debt-to-equity ratio of 3.41. The firm has a market capitalization of $4.51 billion, a PE ratio of 38.54 and a beta of 1.82. Sotera Health Company has a twelve month low of $10.80 and a twelve month high of $19.85. The stock has a 50-day simple moving average of $14.96 and a two-hundred day simple moving average of $16.48.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company's quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities analysts predict that Sotera Health Company will post 0.88 EPS for the current fiscal year.

Key Headlines Impacting Sotera Health

Here are the key news stories impacting Sotera Health this week:

• Positive Sentiment: Q1 results beat and outlook reaffirmed — Sotera reported Q1 revenue up ~10% to $280.1M, adjusted EPS of $0.18 (vs. $0.17 consensus) and raised adjusted EBITDA and margin commentary; the company reaffirmed FY‑2026 guidance (5.0%–6.5% revenue growth; 5.5%–7.0% Adj. EBITDA growth) — this is the main catalyst behind today's rally. Read More.
• Positive Sentiment: Analyst support maintained — Piper Sandler reaffirmed an Overweight rating and set a $22 price target (down from $24), implying substantial upside from current levels; continued analyst backing helps sustain investor confidence. Read More.
• Neutral Sentiment: Earnings-call tone and coverage — management set a “steady growth” tone on the Q1 call and analysts/media are highlighting momentum and margin improvement; full call transcript and highlights available for detail if you want to probe segment performance and backlog. Read More.
• Neutral Sentiment: Broader press and transcript coverage — Seeking Alpha, Yahoo Finance and other outlets published the Q1 transcript/recap and noted the revenue/EPS beats and stock reaction; useful for drilling into management commentary and segment KPIs. Read More.
• Negative Sentiment: Leadership transition introduces near-term uncertainty — Sotera announced a planned CEO transition (new CEO Alton Shader effective May 26; current CEO to become Executive Chairman). It's orderly but any management change can create execution risk until the new CEO is fully in place. Read More.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the completion of the transaction, the director owned 12,735,301 shares of the company's stock, valued at $194,468,046.27. The trade was a 43.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 15.36% of the stock is owned by insiders.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.